These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9157332)

  • 1. Apomorphine and dopamine D(1) receptor agonists increase the firing rates of subthalamic nucleus neurons.
    Kreiss DS; Anderson LA; Walters JR
    Neuroscience; 1996 Jun; 72(3):863-76. PubMed ID: 9157332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine agonist-mediated rotation in rats with unilateral nigrostriatal lesions is not dependent on net inhibitions of rate in basal ganglia output nuclei.
    Ruskin DN; Bergstrom DA; Mastropietro CW; Twery MJ; Walters JR
    Neuroscience; 1999; 91(3):935-46. PubMed ID: 10391472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological effects of SKF 38393 in rats with reserpine treatment and 6-hydroxydopamine-induced nigrostriatal lesions reveal two types of plasticity in D1 dopamine receptor modulation of basal ganglia output.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1434-43. PubMed ID: 7996456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic nucleus lesions alter basal and dopamine agonist stimulated electrophysiological output from the rat basal ganglia.
    Zahr NM; Martin LP; Waszczak BL
    Synapse; 2004 Nov; 54(2):119-28. PubMed ID: 15352137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute reduction of dopamine levels alters responses of basal ganglia neurons to selective D-1 and D-2 dopamine receptor stimulation.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Eur J Pharmacol; 1988 Aug; 152(3):289-300. PubMed ID: 2906003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming of a D1 dopamine receptor behavioural response is dissociated from striatal immediate-early gene activity.
    Paul ML; Currie RW; Robertson HA
    Neuroscience; 1995 May; 66(2):347-59. PubMed ID: 7477877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease.
    Kreiss DS; Mastropietro CW; Rawji SS; Walters JR
    J Neurosci; 1997 Sep; 17(17):6807-19. PubMed ID: 9254691
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of microiontophoretic application of dopamine on subthalamic nucleus neuronal activity in normal rats and in rats with unilateral lesion of the nigrostriatal pathway.
    Ni Z; Gao D; Bouali-Benazzouz R; Benabid AL; Benazzouz A
    Eur J Neurosci; 2001 Jul; 14(2):373-81. PubMed ID: 11553287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
    Hassani OK; Féger J
    Neuroscience; 1999; 92(2):533-43. PubMed ID: 10408602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nigrostriatal lesion and dopamine agonists affect firing patterns of rodent entopeduncular nucleus neurons.
    Ruskin DN; Bergstrom DA; Walters JR
    J Neurophysiol; 2002 Jul; 88(1):487-96. PubMed ID: 12091570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excitation of type II caudate neurons by systemic administration of dopamine agonists.
    Piercey MF; Hyslop DK; Hoffmann WE
    Brain Res; 1996 Jan; 706(2):249-58. PubMed ID: 8822364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of D1 and D2 dopamine receptor stimulation on the activity of substantia nigra pars reticulata neurons in 6-hydroxydopamine lesioned rats: D1/D2 coactivation induces potentiated responses.
    Weick BG; Walters JR
    Brain Res; 1987 Mar; 405(2):234-46. PubMed ID: 2952219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nigrostriatal lesion alters neurophysiological responses to selective and nonselective D-1 and D-2 dopamine agonists in rat globus pallidus.
    Carlson JH; Bergstrom DA; Demo SD; Walters JR
    Synapse; 1990; 5(2):83-93. PubMed ID: 2309160
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons.
    Carlson JH; Bergstrom DA; Weick BG; Walters JR
    Synapse; 1987; 1(5):411-6. PubMed ID: 2975067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multisecond oscillations in firing rate in the basal ganglia: robust modulation by dopamine receptor activation and anesthesia.
    Ruskin DN; Bergstrom DA; Kaneoke Y; Patel BN; Twery MJ; Walters JR
    J Neurophysiol; 1999 May; 81(5):2046-55. PubMed ID: 10322046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D1 dopamine receptors influence Fos immunoreactivity in the globus pallidus and subthalamic nucleus of intact and nigrostriatal-lesioned rats.
    Ruskin DN; Marshall JF
    Brain Res; 1995 Dec; 703(1-2):156-64. PubMed ID: 8719628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393.
    Ruskin DN; Rawji SS; Walters JR
    J Pharmacol Exp Ther; 1998 Jul; 286(1):272-81. PubMed ID: 9655869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrastriatal injection of D1 or D2 dopamine agonists affects glucose utilization in both the direct and indirect pathways of the rat basal ganglia.
    Conti G; Blandini F; Tassorelli C; Giubilei F; Fornai F; Zocchi A; Orzi F
    Neurosci Lett; 2001 Aug; 309(3):161-4. PubMed ID: 11514066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multisecond oscillations in the subthalamic nucleus: effects of apomorphine and dopamine cell lesion.
    Allers KA; Kreiss DS; Walters JR
    Synapse; 2000 Oct; 38(1):38-50. PubMed ID: 10941139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.